A clinical audit of the utilisation of red blood cell products in elective total hip replacement surgery

Please use this identifier to cite or link to this item: https://etd.cput.ac.za/handle/20.500.11838/2239

DC Field	Value	Language
dc.contributor.advisor	Davison, Glenda Mary	en
dc.contributor.advisor	Bellairs, Greg	en
dc.contributor.advisor	Bird, Arthur	en
dc.contributor.author	Peters, Yvonne Grace	-
dc.date.accessioned	2016-04-20T08:22:11Z	-
dc.date.accessioned	2016-09-15T09:27:22Z	-
dc.date.available	2016-04-20T08:22:11Z	-
dc.date.available	2016-09-15T09:27:22Z	-
dc.date.issued	2015	-
dc.identifier.uri	http://hdl.handle.net/20.500.11838/2239	-
dc.description	Thesis (MTech (Biomedical Sciences))--Cape Peninsula University of Technology, 2015.	en_US
dc.description.abstract	Previous international studies have documented a marked variation in transfusion practice for Total Hip Replacement (THR) surgery. This is despite widespread dissemination of clinical guidelines for the use of blood products. The cost and potential wastage of blood products as well as concerns regarding patient care and outcomes are important drivers of optimal blood management. The aim of this study was to audit red cell product utilisation for THR surgeries at two tertiary referral hospitals.	en_US
dc.language.iso	en	en_US
dc.publisher	Cape Peninsula University of Technology	en_US
dc.rights.uri	http://creativecommons.org/licenses/by-nc-sa/3.0/za/	en
dc.subject	Total hip replacement	en_US
dc.subject	Blood -- Transfusion	en_US
dc.subject	Erythrocytes	en_US
dc.title	A clinical audit of the utilisation of red blood cell products in elective total hip replacement surgery	en_US
dc.type	Thesis	en_US
Appears in Collections:	Biomedical Technology - Masters Degrees